title: Prolonged administration over six hours of large doses of intravenous iron saccharate (500 mg) prevents severe adverse reactions in peritoneal dialysis patients.
authors.forename: H K
authors.initials: HK
authors.lastname: Aggarwal
authors.forename: E
authors.initials: E
authors.lastname: Tziviskou
authors.forename: V
authors.initials: V
authors.lastname: Bellizzi
authors.forename: M
authors.initials: M
authors.lastname: Khandelwal
authors.forename: L
authors.initials: L
authors.lastname: Moupas
authors.forename: J M
authors.initials: JM
authors.lastname: Bargman
authors.forename: S V
authors.initials: SV
authors.lastname: Jassal
authors.forename: D G
authors.initials: DG
authors.lastname: Oreopoulos
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018798:Anemia, Iron-Deficiency / Q000209:etiology* / Q000517:prevention & control*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004342:Drug Hypersensitivity / Q000209:etiology* / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007501:Iron / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D007674:Kidney Diseases / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D014677:Pharmaceutical Vehicles / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D014677:Pharmaceutical Vehicles; D007501:Iron